IHS, Tribal and Urban Indian (I/T/U) Organization Resources

The following information is for IHS, Tribal Health Programs, and Urban Indian Organizations that will receive vaccine from IHS.

Employee Resources

IHS employees are encouraged to be educated and empowered to recognize coronavirus scams. The COVID Vaccine Cybersecurity Awareness provides useful tips and information.

Clinician Resources

Contacts

• Area Vaccine Points of Contact [PDF - 114 KB]
• VAMS Area Points of Contact [PDF - 138 KB]

Documents and Forms

The following forms are meant for PRINT USE ONLY and were not designed for use as a digital medium. Please contact IHSSection508@ihs.gov for any questions about accessibility for these forms.

• COVID-19 Vaccine Data Management Documents and Forms

Reporting

• COVID-19 Vaccine Data Management Reporting

Safety and Monitoring

• The IHS National Pharmacy & Therapeutics Committee provides content and guidance on COVID-19 related issues for I/T/U providers. NPTC COVID-19 clinical information.

Temperature Excursions

• IHS Temporary Guidance on COVID-19 Vaccine Temperature Excursions [PDF - 119 KB]
• IHS Temperature Excursions Worksheet (Revised 07/25/2022) [PDF - 389 KB]

  Please download the file and open it in Adobe Acrobat to fill out the form fields.

Training

• COVID-19 Vaccine Provider Training Checklist (revised 07/25/2022). [PDF - 727 KB]
• IHS COVID-19 Vaccine General Competency EXAMPLE Exam (revised 05/12/2023). [PDF - 188 KB]
• IHS Novavax COVID-19 Vaccine EXAMPLE Competency Exam (revised 05/12/2023). [PDF - 177 KB]
• IHS Bivalent Boosters COVID-19 Vaccine EXAMPLE Competency Exam (revised 05/12/2023). [PDF - 157 KB]

IHS COVID-19 Webinar Recordings (See: For all Archived TBHCE COVID-19 Trainings). The following recordings may not be fully accessible to persons using assistive technology. For assistance with the information below, please contact the IHS Tele-Education Team by email at: IHSTele-Education@ihs.gov. 

• 11/9/2021: COVID-19 Vaccine Update – Pediatric Vaccine Recommendations, Safety and Effectiveness
• 10/28/021: COVID-19 Vaccine Update – Booster Dose Recommendations, Safety and Effectiveness
• 09/19/2021: COVID-19 Vaccine Update – Additional Doses, Safety and Age Indications
• 2/25/2021: IHS COVID-19 Implementation Progress and Safety Update
• 12/18/2020: IHS COVID-19 Response Webinar Series: IHS COVID-19 Vaccine Implementation and Administration
• 11/20/2020: IHS COVID-19 Response Webinar Series: IHS COVID-19 Vaccine Planning and Implementation

Redistribution Information

• IHS Supplemental Redistribution Guidance and Worksheet [PDF - 1.0 MB]
• CDC COVID-19 Vaccine Allocation Transfer and Redistribution Guidance for IHS and Tribal Facilities [PDF]

This document was provided by the Centers for Disease Control (CDC) and may not be fully accessible to persons using assistive technology. For assistance with the information in this file, please contact the IHS Office of Public Health Support at 301-443-0222.

• COVID-19 Vaccine Redistribution Agreement for Tribal Health Program and Urban Indian Organization [PDF - 285 KB]

Resources

Centers for Disease Control and Prevention

• COVID-19 Vaccination Program Interim Playbook for Jurisdiction Operations Version 2.0 Exit Disclaimer: You Are Leaving www.ihs.gov , October 29, 2020
• 10 Things Healthcare Professionals Need to Know about U.S. COVID-19 Vaccination Plans Exit Disclaimer: You Are Leaving www.ihs.gov 
• About COVID-19 Vaccines Exit Disclaimer: You Are Leaving www.ihs.gov 
• COVID-19 Vaccination Communication Toolkit Exit Disclaimer: You Are Leaving www.ihs.gov 
• How CDC Is Making COVID-19 Vaccine Recommendations Exit Disclaimer: You Are Leaving www.ihs.gov 
• Ensuring the Safety of COVID-19 Vaccines Exit Disclaimer: You Are Leaving www.ihs.gov 
• Ensuring COVID-19 Vaccines Work Exit Disclaimer: You Are Leaving www.ihs.gov 
• Frequently Asked Questions about COVID-19 Vaccination Exit Disclaimer: You Are Leaving www.ihs.gov 
• Pre-Vaccination Checklist for COVID-19 Vaccines [PDF - 157 KB]
• Vaccination Training Programs and Reference Materials Exit Disclaimer: You Are Leaving www.ihs.gov 

Food and Drug Administration

• Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss COVID-19 Vaccine Candidate , November 20, 2020 Exit Disclaimer: You Are Leaving www.ihs.gov 
• COVID-19 Vaccines Exit Disclaimer: You Are Leaving www.ihs.gov 
• Development and Licensure of Vaccines to Prevent COVID-19 Exit Disclaimer: You Are Leaving www.ihs.gov , June 30, 2020
• Emergency Use Authorization Exit Disclaimer: You Are Leaving www.ihs.gov 
• Emergency Use Authorization for Vaccines Explained Exit Disclaimer: You Are Leaving www.ihs.gov 
• Emergency Use Authorization for Vaccines to Prevent COVID-19; Guidance for Industry Exit Disclaimer: You Are Leaving www.ihs.gov 
• Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry Exit Disclaimer: You Are Leaving www.ihs.gov 
• Fact Sheet for Healthcare Providers Administering Vaccine (Vaccine Providers) Exit Disclaimer: You Are Leaving www.ihs.gov 
• Fact Sheet for Recipients and Caregivers Exit Disclaimer: You Are Leaving www.ihs.gov 
• Pfizer-BioNTech COVID-19 Vaccine Exit Disclaimer: You Are Leaving www.ihs.gov 
• Pfizer-BioNTech COVID-19 Vaccine EUA Letter of Authorization Exit Disclaimer: You Are Leaving www.ihs.gov 
• Press Release FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine Exit Disclaimer: You Are Leaving www.ihs.gov 
• Vaccine Development - 101 Exit Disclaimer: You Are Leaving www.ihs.gov 
• Vaccines and Related Biological Products Advisory Committee - October 22, 2020 Exit Disclaimer: You Are Leaving www.ihs.gov .